These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15281003)

  • 61. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization.
    Tertov VV; Sobenin IA; Gabbasov ZA; Popov EG; Jaakkola O; Solakivi T; Nikkari T; Smirnov VN; Orekhov AN
    Lab Invest; 1992 Nov; 67(5):665-75. PubMed ID: 1434544
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The inflammatory properties of electronegative low-density lipoprotein from type 1 diabetic patients are related to increased platelet-activating factor acetylhydrolase activity.
    Sánchez-Quesada JL; Benítez S; Pérez A; Wagner AM; Rigla M; Carreras G; Vila L; Camacho M; Arcelus R; Ordóñez-Llanos J
    Diabetologia; 2005 Oct; 48(10):2162-9. PubMed ID: 16132957
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-density lipoprotein particle size in type 2 diabetic patients and age matched controls.
    Stewart JM; Kilpatrick ES; Cathcart S; Small M; Dominiczak MH
    Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():153-9. PubMed ID: 8060094
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Characterization of chemical composition of native and modified low density lipoprotein occurring in the blood of diabetic patients.
    Sobenin IA; Tertov VV; Orekhov AN
    Int Angiol; 1994 Mar; 13(1):78-83. PubMed ID: 8077803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia.
    Patti L; Maffettone A; Iovine C; Marino LD; Annuzzi G; Riccardi G; Rivellese AA
    Atherosclerosis; 1999 Oct; 146(2):361-7. PubMed ID: 10532692
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Core lipid structure is a major determinant of the oxidative resistance of low density lipoprotein.
    Schuster B; Prassl R; Nigon F; Chapman MJ; Laggner P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2509-13. PubMed ID: 7708675
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oxidative modification of low-density lipoprotein and atherogenetic risk in beta-thalassemia.
    Livrea MA; Tesoriere L; Maggio A; D'Arpa D; Pintaudi AM; Pedone E
    Blood; 1998 Nov; 92(10):3936-42. PubMed ID: 9808587
    [TBL] [Abstract][Full Text] [Related]  

  • 69. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper.
    Spranger T; Finckh B; Fingerhut R; Kohlschütter A; Beisiegel U; Kontush A
    Chem Phys Lipids; 1998 Jan; 91(1):39-52. PubMed ID: 9488998
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus.
    Hayashi Y; Okumura K; Matsui H; Imamura A; Miura M; Takahashi R; Murakami R; Ogawa Y; Numaguchi Y; Murohara T
    Metabolism; 2007 May; 56(5):608-13. PubMed ID: 17445534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High levels of dietary advanced glycation end products transform low-density lipoprotein into a potent redox-sensitive mitogen-activated protein kinase stimulant in diabetic patients.
    Cai W; He JC; Zhu L; Peppa M; Lu C; Uribarri J; Vlassara H
    Circulation; 2004 Jul; 110(3):285-91. PubMed ID: 15249511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Endothelial dysfunction in Type 1 diabetes mellitus: relationship with LDL oxidation and the effects of vitamin E.
    Pinkney JH; Downs L; Hopton M; Mackness MI; Bolton CH
    Diabet Med; 1999 Dec; 16(12):993-9. PubMed ID: 10656227
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD.
    Roob JM; Rabold T; Hayn M; Khoschsorur G; Resch U; Holzer H; Winklhofer-Roob BM
    Kidney Int Suppl; 2001 Feb; 78():S128-36. PubMed ID: 11168998
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation.
    Frei B; Gaziano JM
    J Lipid Res; 1993 Dec; 34(12):2135-45. PubMed ID: 8301232
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
    Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
    J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.
    Sobal G; Menzel EJ; Sinzinger H
    Biochem Pharmacol; 2001 Feb; 61(3):373-9. PubMed ID: 11172743
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
    Liu ML; Ylitalo K; Nuotio I; Salonen R; Salonen JT; Taskinen MR
    Stroke; 2002 May; 33(5):1255-60. PubMed ID: 11988600
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects.
    Dobrian A; Simionescu M
    Biochim Biophys Acta; 1995 Jan; 1270(1):26-35. PubMed ID: 7827132
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine.
    Abu-Amsha R; Croft KD; Puddey IB; Proudfoot JM; Beilin LJ
    Clin Sci (Lond); 1996 Oct; 91(4):449-58. PubMed ID: 8983870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome).
    Calò L; Sartore G; Bassi A; Basso C; Bertocco S; Marin R; Zambon S; Cantaro S; D'Angelo A; Davis PA; Manzato E; Crepaldi G
    J Hypertens; 1998 Jul; 16(7):1001-8. PubMed ID: 9794741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.